23 May 2013
Keywords: USA, Biotech development, BioSante, AVI BioPharma, Bedford Report, USA
Article | 20 July 2011
There is plenty of optimism surrounding the US biotechnology industry as firmer pricing and new products have improved sales and ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
20 July 2011
© 2013 thepharmaletter.com